Literature DB >> 25485949

Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids.

Ritva Karinen1, Silja Skogstad Tuv2, Elisabeth Leere Øiestad2, Vigdis Vindenes2.   

Abstract

A large number of new psychoactive substances are available at the illicit drug market and the synthetic cannabinoids (SCs) are among the substances that have led to serious side effects and death. Knowledge about common concentrations of these drugs are however sparse. Concentrations of APINACA and 5F-APINACA in biological matrixes have previously not been reported, and concentrations of UR-144 and its degradant product in blood samples from driving under the influence of drug (DUID) cases have not been published. The aims of this study were to report concentrations of APINACA, 5F-APINACA, UR-144 and UR-144 degradant from DUID cases analyzed at the Norwegian Institute of Public Health (NIPH), and also previously unpublished concentrations of AM-2201 in cases from our Institute. We have further summarized all the former published studies where concentrations of SCs have been reported, to compare with the results from these newer SCs. In whole blood from one driver we have found 5F-APINACA and from three drivers both APINACA and 5F-APINACA in concentrations from 0.24 to 24.5 and 0.9 to 6.5 μg/L, respectively, and UR-144 in two cases in concentrations of 0.22 and 0.47 μg/L. UR-144 degradant in a concentration of 0.15 μg/L was found in one of the cases. A summary of the literature reveals major deficiencies regarding concentrations of most of the SCs. The SCs most frequently detected in DUID cases were (n≥8) AM-2201, JWH-122, JWH-018 and JWH-210. In intoxication cases AM-2201 (n=517) was the most often detected SC, followed by JWH-122, JWH-210, UR-144, JWH-018, and MAM-2201 (n>100). Four studies regarding concentrations in autopsy cases have been published, and concentrations of four different SCs have been reported (JWH-018, JWH-073, JWH-210, AM-2201 and the metabolites of AM-2201; 4-OH-pentyl, JWH-018 5-OH-pentyl and JWH-018 pentanoic acid). Pharmacokinetic data are only available for JWH-018 (n=3), JWH-073 (n=1) and the metabolites of AM-2201; 4-OH-pentyl, 6-OH-indole, JWH-018 5-OH-pentyl and JWH-018 pentanoic acid (n=1).
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Autopsy cases; DUID cases; Intoxications; Pharmacokinetic studies; Synthetic cannabinoids

Mesh:

Substances:

Year:  2014        PMID: 25485949     DOI: 10.1016/j.forsciint.2014.11.012

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  15 in total

1.  Synthetic cannabinoid, JWH-030, induces QT prolongation through hERG channel inhibition.

Authors:  Jaesuk Yun; Kyung Sik Yoon; Tac-Hyung Lee; Hyunjin Lee; Sun Mi Gu; Yun Jeong Song; Hye Jin Cha; Kyoung Moon Han; Hyewon Seo; Jisoon Shin; Hye-Kyung Park; Hyung Soo Kim; Young-Hoon Kim
Journal:  Toxicol Res (Camb)       Date:  2016-09-07       Impact factor: 3.524

2.  A synthetic cannabinoid JWH-210 reduces lymphoid organ weights and T-cell activator levels in mice via CB2 receptors.

Authors:  Sun Mi Gu; Hyun Jin Lee; Tac-Hyung Lee; Yun Jeong Song; Young-Hoon Kim; Kyoung-Moon Han; Jisoon Shin; Hye-Kyung Park; Hyung Soo Kim; Hye Jin Cha; Jaesuk Yun
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-08-22       Impact factor: 3.000

3.  Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.

Authors:  Thomas F Gamage; Charlotte E Farquhar; Timothy W Lefever; Julie A Marusich; Richard C Kevin; Iain S McGregor; Jenny L Wiley; Brian F Thomas
Journal:  J Pharmacol Exp Ther       Date:  2018-03-16       Impact factor: 4.030

4.  Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.

Authors:  Isabella Canazza; Andrea Ossato; Claudio Trapella; Anna Fantinati; Maria Antonietta De Luca; Giulia Margiani; Fabrizio Vincenzi; Claudia Rimondo; Fabiana Di Rosa; Adolfo Gregori; Katia Varani; Pier Andrea Borea; Giovanni Serpelloni; Matteo Marti
Journal:  Psychopharmacology (Berl)       Date:  2016-08-15       Impact factor: 4.530

Review 5.  Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs.

Authors:  Francesco Paolo Busardo; Simona Pichini; Manuela Pellegrini; Angelo Montana; Alfredo Fabrizio Lo Faro; Simona Zaami; Silvia Graziano
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 6.  Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.

Authors:  Aviv M Weinstein; Paola Rosca; Liana Fattore; Edythe D London
Journal:  Front Psychiatry       Date:  2017-08-23       Impact factor: 4.157

7.  In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters.

Authors:  Sunjoo Kim; Won-Gu Choi; Mihwa Kwon; Sowon Lee; Yong-Yeon Cho; Joo Young Lee; Han Chang Kang; Im-Sook Song; Hye Suk Lee
Journal:  Molecules       Date:  2019-08-19       Impact factor: 4.411

Review 8.  Emerging drugs of abuse: current perspectives on synthetic cannabinoids.

Authors:  Danièle Debruyne; Reynald Le Boisselier
Journal:  Subst Abuse Rehabil       Date:  2015-10-20

9.  New psychoactive substance α-PVP in a traffic accident case.

Authors:  Sebastian Rojek; Karol Kula; Martyna Maciów-Głąb; Małgorzata Kłys
Journal:  Forensic Toxicol       Date:  2016-04-02       Impact factor: 4.096

10.  Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice.

Authors:  Cornelius Hess; Clara T Schoeder; Thanigaimalai Pillaiyar; Burkhard Madea; Christa E Müller
Journal:  Forensic Toxicol       Date:  2016-05-17       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.